ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,960,298 | -25.2% | 259,036 | 0.0% | 2.07% | +5.5% |
| Q2 2023 | $9,307,163 | +41.5% | 259,036 | 0.0% | 1.96% | -11.2% |
| Q1 2023 | $6,579,514 | -25.8% | 259,036 | +17.2% | 2.21% | -34.3% |
| Q4 2022 | $8,867,122 | +51.9% | 221,015 | +26.0% | 3.36% | +58.5% |
| Q3 2022 | $5,837,000 | -5.5% | 175,393 | 0.0% | 2.12% | +3.7% |
| Q2 2022 | $6,176,000 | -26.5% | 175,393 | -4.0% | 2.05% | +10.1% |
| Q1 2022 | $8,403,000 | -39.0% | 182,717 | -10.6% | 1.86% | -31.9% |
| Q4 2021 | $13,766,000 | – | 204,393 | – | 2.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |